Karl Nislow (he/they)

Karl Nislow is a versatile business strategist, finance leader, and investor. Currently, he serves as a fractional executive and advisor for several health and wellness startups, with a focus on scaling early-stage brands across technology, health tech, and consumer goods.

Active in the longevity and biohacker communities, Karl has played a key role in advancing innovation in the field. From being a foundational member of Bryan Johnson's Blueprint community to helping bring the first consumer phage product to market at Parallel Health (a TC Disrupt 2023 Finalist), his work has been integral to pushing the boundaries of personalized healthcare and biotechnology.